Pembrolizumab trials for Prostate cancer

All Pembrolizumab trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Prostate cancer

• A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
  NCT07255664 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
  NCT07730021 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
  NCT07027124 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
  NCT03753243 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Pembro With Radiation With or Without Olaparib
  NCT05568550 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
  NCT05766371 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
  NCT05563558 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
  NCT04946370 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 4 locations
• TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
  NCT04485013 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 41 locations
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
  NCT04585750 · Phase: Phase 1, Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · 154 locations

Common questions

How many trials study Pembrolizumab for Prostate cancer?

10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.